Showing 11-20 of 48 grants
Title | Institution | Researcher | Program | Duration | Total Award Amount |
---|---|---|---|---|---|
Transcriptional memory in human islet organogenesis | Lundquist Institute for Biomedical Medical Innovation at Harbor‐UCLA Medical Center (The Lundquist Institute) | Eiji Yoshihara | Cures | 01-April-2022 to 31-March-2027 | $749,995.50 |
Real time monitoring of a cell therapy product to assess and modify transplant health post-engraftment in patients with type 1 diabetes | Minutia | Katy Digovich | Cures | 01-November-2022 to 30-November-2025 | $1,198,600.00 |
Effects of Volagidemab on Glucagon Rescue from Insulin-Induced Hypoglycemia | REMD Biotherapeutics | Dung Thai | Improving Lives | 30-June-2023 to 29-June-2026 | $672,000.00 |
Inflammatory cytokines rewire the proinsulin interaction network in human islets | Sanford-Burnham Medical Research Institute | Pamela Itkin-Ansari | Cures | 01-May-2022 to 30-April-2025 | $987,642.98 |
Novel insulin formulations for pumps | Stanford University | Yanxian Zhang | Improving Lives | 01-March-2023 to 28-February-2026 | $243,986.00 |
Single-arm intervention trial of TWIIST™ AID DEKA Loop insulin pump in pregnant women with pre-existing type 1 diabetes | Stanford University | Tugce Akcan | Improving Lives | 01-March-2025 to 28-February-2027 | $180,600.00 |
A Magnetic Pumping Mechanism for Miniaturized High-Accuracy External Insulin Pump | Stanford University | Renee Zhao | Improving Lives | 01-May-2022 to 30-April-2025 | $676,000.00 |
Endothelial cells for islet replacement in diabetes | Stanford University | Martin Neukam | Cures | 01-April-2024 to 31-March-2027 | $251,600.00 |
Development of an injectable immunomodulatory niche technology for induction of immune tolerance to islet cell transplants | Stanford University | Eric Appel | Cures | 01-January-2025 to 31-December-2026 | $600,000.00 |
Ultrafast Insulin-Pramlintide Co-formulations | Stanford University | Eric Appel | Improving Lives | 01-September-2022 to 31-August-2025 | $795,000.00 |